Please enable JS

DISCOVER

INVESTIGATOR SITE MANAGEMENT

Clinical Trials Mobile Application

We provide innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.

Get a demo

Our mission

SOME NUMBERS

Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.
CT-SCOUT and ToTem4me facilitate the match between the patients and the studies.

50%

OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES

However, millions of patients visit clinical sites every day.
CT-SCOUT help investigators identify the ones that could benefit from a clinical study.

80%

OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.

0.02%

OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY

But 80% of patients would accept to participate t a clinical study.
CT-SCOUT contributes to increase the percentage of patients considered for clinical research.

2

WEEKS SET-UP TIME

No more than 2 weeks are required to get CT-SCOUT
or ToTem4me deployed for a clinical study

Our Solutions

We have customised digital solutions for the different contributors to the clinical research efforts.

corner top

CT-SCOUT

The missing link between sponsor & sites

A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.

Find out more corner bottom
corner top

ToTem4me

The web application for patients

A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in their neighborhood, for which they are potentially eligible according to their current health conditions and to inform the corresponding physicians of their potential willingness to participate.

Find out more corner bottom
corner top

eISF

The electronic investigator site file

The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements.

Find out more corner bottom

LATEST NEWSOUR NEWS >

telemedecine technologies news

DMEA 2024 – Berlin

March 29, 2024

April 10 & 11, 2024 Telemedicine Technologies and OVHcloud are partnering to host health data collected in hospitals for medical research studies using the CleanWeb™ software suite. This collaboration allows Telemedicine Technologies to benefit from OVHcloud’s support, including 24/7 assistance and guarantees such as data localisation in France and transparency in data processing practices. DMEA […]

READ MORE
telemedecine technologies news

Improving Diversity in Clinical Trials

March 29, 2024

Applied Clinical Trials Online A lack of diversity in clinical trials is a critical issue, as racial and ethnic subgroups may respond differently to therapies, potentially undermining efficacy and safety outcomes and producing results that are not representative of the patients who will receive the treatment in the real world. Furthermore, clinical trials provide access […]

READ MORE
telemedecine technologies news

Innovation package: METAglut1 is reimbursed under common law

March 29, 2024

Mind health The startup Metafora Biosystems, which develops a platform for cellular metabolism analysis, announced on March 11th the reimbursement approval in France for its METAglut1 test, aiding in the diagnosis of Glut1 transporter deficiency syndrome since February 15th. This blood-based test is less invasive than the previously preferred lumbar puncture. It’s the first healthcare […]

READ MORE